Next Article in Journal
Protein Structure-Guided Hidden Markov Models (HMMs) as A Powerful Method in the Detection of Ancestral Endogenous Viral Elements
Next Article in Special Issue
BK Virus Replication in the Glomerular Vascular Unit: Implications for BK Virus Associated Nephropathy
Previous Article in Journal
Characterization of Two Pseudomonas aeruginosa Viruses vB_PaeM_SCUT-S1 and vB_PaeM_SCUT-S2
Previous Article in Special Issue
Clinical, Histopathologic, and Immunohistochemical Characterization of Experimental Marburg Virus Infection in A Natural Reservoir Host, the Egyptian Rousette Bat (Rousettus aegyptiacus)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Stillborn Multiple Organs’ Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization

by
Priscila Nunes
1,
Rita Nogueira
2,
Janice Coelho
3,
Francisco Rodrigues
3,
Natália Salomão
4,
Carollina José
4,
Jorge de Carvalho
5,
Kíssila Rabelo
5,
Elzinandes de Azeredo
1,
Rodrigo Basílio-de-Oliveira
6,
Carlos Basílio-de-Oliveira
6,
Flávia dos Santos
1,† and
Marciano Paes
4,*,†
1
Laboratório de Imunologia Viral, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil
2
Laboratório de Flavivirus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro 21040-900, Brazil
3
Laboratório de Anatomia Patológica, Instituto Nacional de Infectologia, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro 21040-900, Brazil
4
Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro 21040-900, Brazil
5
Laboratório de Ultraestrutura e Biologia Tecidual, Universidade do Estado do Rio de Janeiro/UERJ, Rio de Janeiro 20551-030, Brazil
6
Anatomia Patológica, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro 20270-901, Brazil
*
Author to whom correspondence should be addressed.
These authors contributed equally to the work.
Viruses 2019, 11(4), 319; https://doi.org/10.3390/v11040319
Submission received: 15 January 2019 / Revised: 18 February 2019 / Accepted: 20 February 2019 / Published: 2 April 2019
(This article belongs to the Special Issue Pathogenesis of Emerging Viral Infections)

Abstract

:
Dengue virus (DENV) is an emerging virus involved in outbreaks in Brazil. The association between the virus and vertical transmission, with disorders in the placenta, has raised a worldwide concern. On the 29th gestational week, a pregnant woman presented severe complications due to a DENV infection leading to maternal and fetus death. Postmortem analysis of fetal organs demonstrated the presence of DENV using reverse transcriptase polymerase chain reaction (RT-PCR) in the fetal brain and DENV non-structural protein 3 (NS3) staining in placenta and several peripheral fetal tissues, such as the brain, liver, lungs, and spleen. Histological analysis of the placenta and fetal organs revealed different types of tissue abnormalities, which included inflammation, hemorrhage, edema, and necrosis in placenta and tissue disorganization in the fetus, such as spongiform parenchyma, microglial inflammation, steatosis, hyalinose arteriolar, inflammatory cells in the alveolar septa, and disorganization of the lymphoid follicle. Increased cellularity (macrophage, Hofbauer cells and TCD8+ lymphocytes) and up-regulation of inflammatory mediators such as IFN-γ, TNF-α, RANTES/CCL5, MCP1/CCL2, and VEGF/R2 were detected in the liver, lung, spleen, brain, and placenta, supporting placental and fetus peripheral tissues inflammation. Maternal infection leading to the production of those vascular mediators may alter the vascular permeability, facilitating the virus entry and tissue and barrier dysfunction.

1. Introduction

Dengue is a mosquito-borne viral disease endemic in many tropical and subtropical regions worldwide [1]. Approximately half of world’s population is at risk of infection by one of the four Dengue virus (DENV) serotypes [2]. In Brazil, dengue emerged as a public health problem after DENV-1 was introduced in 1986 [3]. After 32 years, four DENV serotypes are currently co-circulating [4].
Despite its first detection in Roraima 1981, which is north of Brazil [5], it was only in 2010 that DENV-4 was reintroduced [6] and spread to other states in the country, including Rio de Janeiro (RJ) in the Southeast region [7]. Due to the populations’ susceptibility to this newly introduced serotype, explosive epidemics in the country were a real threat and the impact of the DENV-4 emergence in an endemic region where the other three serotypes were circulating was unknown [8]. DENV-4 spread countrywide and caused explosive epidemics in the following years. In 2013, Brazil experienced an intense epidemic, with the co-circulation of the four serotypes and a total of 1,452,489 reported cases. RJ reported a total of 213,058 dengue cases, about 15% of the whole country [9]. In fact, DENV-4 was responsible for the highest number of cases in RJ and the metropolitan region was responsible for most cases in 2013.
The disease has a broad clinical spectrum, from asymptomatic and oligosymptomatic forms to severe conditions [10]. Currently, the World Health Organization (WHO) 2009 guidelines classify the illness as dengue without warning signs, dengue with warning signs, and severe dengue [11]. Severe dengue can be characterized by severe bleeding, severe organ involvement, and severe plasma leakage; most deaths are associated to this condition. In the absence of supportive care, severe dengue fatality can occur in approximately 4% of cases [12]. DENV-4 is known as a mild serotype and has been associated to severe and fatal cases in Brazil [8]. Histopathological analysis in dengue fatal cases has demonstrated alterations and/or inflammatory reactions in the liver, spleen, kidney, lung, heart, and central nervous system [13,14,15,16,17,18,19,20,21].
Pregnant women and neonates are considered to be at increased risk of a more severe disease [22,23]. Although there is no consensus regarding the effects of the disease on this vulnerable group, some studies indicate that vertical transmission may occur and cause serious consequences, such as preterm delivery and fetal death [24,25,26,27,28]. There is some evidence that the risk of severe dengue and hospitalization is higher among pregnant women compared to non-pregnant women [29] and that the maternal natural immunosuppression during pregnancy may favor the occurrence of a more severe infection [30]. Immunohistochemical analysis revealed a systemic involvement of infection with mononuclear cells targeted to all of the tissues analyzed. Assessment of local cytokine response showed increased levels of IFN-γ- and TNF-α-expressing cells in all tissues that evidenced a consistent pro-inflammatory induction and inflammatory mediators.
Maternal–fetal interface studies are still in need, as several agents, including arboviruses, can be transmitted from mother to her offspring, leading to a wide spectrum of outcomes [31]. Despite the efforts and studies worldwide [23,27,28,29,30,32,33,34,35,36,37,38,39,40,41], the burden of dengue during pregnancy on the mother/child pair is not fully understood, but shall be undoubtedly be taken seriously, especially where multiple arboviruses co-circulate, such as in Brazil [27]. Here, we sought to investigate multiple organs of a fetus from an abortion occurred in a DENV-4 infected pregnant woman during the outbreak in RJ in 2013.

2. Materials and Methods

2.1. Case

A 29-week-old pregnant woman, 36 years old, resident of Itaboraí, metropolitan region of RJ, started a febrile illness with vomiting, arthralgia, headache, and epigastria on 03/16/2013. She was admitted to a hospital in RJ on 03/17/2013, presenting a leukocyte count of 13,000/mm³, hematocrit of 33.7%, platelet count of 276,000/mm³, and a positive result for a DENV non-structural protein 1 (NS1) antigen. She was dismissed and requested to return within 48 h for a new evaluation. On 03/22/13, the patient returned to the health unit with pain in the lower limbs, vaginal bleeding, a leukocyte count of 14,000/mm³, a hematocrit of 34.3%, and a platelet count of 112,000 mm³. She was hospitalized in the intensive care unit (ICU). The following day, she had intense bleeding, blood pressure of 13 × 10, vomiting with blood, a leukocyte count of 445,000/mm³, a hematocrit of 26.5%, and a platelet count of 56,000/mm³. The ultrasound revealed a stillborn; vaginal delivery was performed. The fetus was detached from the placenta and an autopsy was performed. Fragments of liver, spleen, brain, lung, and placenta were collected and sent to the Flavivirus Laboratory, FIOCRUZ on 03/27/2013 for case investigation. After vaginal delivery, she remained in the ICU, but died 11 days later, on 04/02/13. No autopsy was performed at that time. The case was classified as Dengue with Complications (DCC), according the criteria established by the Brazilian Ministry of Health in 2000. DCC was established to define severe dengue cases that did not meet the 1997 WHO criteria for dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).

2.2. Ethical Considerations

The samples used in this study were received as convenience samples at the Flavivirus Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Regional Reference Center for Dengue, Yellow Fever, Chikungunya, and Zika for the Brazilian Ministry of Health. This study was approved by the Research Ethics Committee (CEP 274/05 and CAAE: 57221416.0.1001.5248) of the Oswaldo Cruz Foundation, Ministry of Health, Brazil.

2.3. Molecular Diagnosis, Histopathological Analysis, and Immunohistochemistry

Tissues samples from necropsy were paraffin-embedded, fixed in 10% formalin, cut (4 µm), deparaffinized in xylene and rehydrated with alcohol, as described elsewhere [18]. For the paraffin-embedded viral ribonucleic acid (RNA) extraction, three 5-μm slices of each fragment were used and submitted separately to the PureLink ™ FFPE RNA Isolation Kit (Invitrogen, Carlsbad, CA, USA). The reverse transcriptase polymerase chain reaction (RT-PCR) for DENV identification and serotyping was performed as described by Lanciotti et al. [42]. Tissues sections were stained with hematoxylin and eosin for histological examination and visualized using light microscopy (Olympus, Tokyo, Japan); digital images were obtained using Image Pro Plus software version 4.5 (Media Cybernetics, Rockville, MD, USA). For immunohistochemical studies, antigen retrieval was performed by heating the tissue in the presence of EnVision Flex target retrieval solution high pH (Dako, Palo Alto, CA, USA) or citrate buffer. Tissues were blocked for endogenous peroxidase with 3% hydrogen peroxidase in methanol and rinsed in Tris-HCl (pH 7.4). To reduce non-specific binding, sections were incubated for 30 min at room temperature. Samples were then incubated overnight at 4 °C with anti-DENV NS3 recombinant antibody [18], rabbit anti-human CD4 monoclonal antibody clone SP35 (Spring Bioscience, Pleasanton, CA, USA), mouse anti-human CD8 Clone C8/144B (Dako, Palo Alto, CA, USA), macrophage antibody CD68 clone EBM11 (Dako, Palo Alto, CA, USA), anti-MCP 1 monoclonal antibody (Novus Biologicals, Centennial, CO, USA), anti-TNF alpha antibody, Clone ab6671 (Abcam, MA, USA), goat IFN-γ (D-17) polyclonal antibody (Santa Cruz Biotechnology, Dallas, TX, USA), anti-RANTES antibody, and Clone ab189841 (Abcam, Cambridge, MA, USA); anti-VEGF/R2 (Spring Bioscience, Pleasanton, CA, USA). The next day, the sections were incubated with REVEAL COMPLEMENT secondary antibody (Spring Bioscience, Pleasanton, CA, USA) for 10 min and a REVEAL-HRP secondary antibody conjugate (Spring Bioscience, Pleasanton, CA, USA) for 15 min at room temperature. The reaction was revealed with diaminobenzidine (Spring Bioscience, Pleasanton, CA, USA), as chromogen and sections were counterstained on Harris hematoxylin (Dako, Palo Alto, CA, USA).

3. Results

Fragments of the liver, lung, spleen, brain, and placenta were available and after viral RNA extraction, the RT-PCR detected DENV-4 infection only in the fetal brain. In the brain, an increase in microglial cells and glial cells was observed in the white matter region (Figure 1B,C). As expected, the brain tissue of a non-infected fetus (negative control) showed a pyramidal neuron layer and white matter with regular structures (Figure 1A). Meningeal thickening presented mononuclear inflammatory infiltrate and DENV NS3 protein was detected in endothelium, macrophages, and microglial cells in the white matter (Figure 1D,E). The inflammatory infiltrates were more diffuse in the white matter with the predominance of microglial cells positive for CD68+ (Figure 1G), while the control only showed CD68 staining in monocytes in the cerebral capillary (Figure 1H). CD8+ T cells were observed in the meningeal, pia mater, and cerebral parenchyma (Figure 1I,J). Microglial cells expressing RANTES, IFN-γ, MCP-1, and VEGF/R2 were identified in the spongiform parenchyma and TNF-α was detected in endothelial cells in the meninger’s vessels (Figure 1L–P).
In the placenta, vacuolization around the maternal decidual cells associated to vascular areas containing mononuclear infiltrate and vascular congestion was observed. Hemorrhage and mononuclear infiltrate were observed in the chorionic villi (Figure 2B,C). In the maternal region, DENV NS3 protein was detected in the endothelial cells from the vessels, in the cytotrophoblasts cells, Hofbauer cells in chorionic villi, macrophages, and decidual cells (Figure 2E,G). Moreover, circulating macrophages and monocytes expressing CD68+ cells in the intervillous space and Hofbauer cells were detected (Figure 2I,J). In addition, in the maternal region, activated CD8+ T cells were detected in the chorionic villus (Figure 2L,O). Expression of TNF-α, IFN-γ, RANTES, and MCP-1 were observed in macrophages, Hofbauer cells, cytotrophoblasts, and endothelial cells. Furthermore, VEGF/R2 was detected in endothelium and lymphocytes (Figure 2Q,U). Controls exhibited normal chorionic villi syncytiotrophoblasts, cytotrophoblasts, and endothelial cells (Figure 2A).
The liver’s negative control showed normal parenchyma and regular central vein and portal space (Figure 3A). The stillborn liver showed a diffuse area of necrotic hepatocytes with mononuclear infiltrate, microesteatosis, macrosteatosis, hyperplasia of Kupffer cells, polyploidy, discrete area of lymphocyte infiltrate in the sinusoidal capillary, thickening of the endothelium in the central vein, and presence of edema (Figure 3B,D). DENV NS3 protein was detected in the Kupffer cells and hepatocytes (Figure 3F) and CD68+ was expressed the hyperplasic Kupffer cells and circulating macrophages (Figure 3G,H). CD8+ and CD4+ T cells were identified inside the hepatocyte’s cytoplasm (Figure 3J,K). Kupffer cells and endothelial cells were expressing TNF-α in macrophages, lymphocytes (Figure 3O), and Kupffer cells expressing IFN-γ and RANTES (Figure 3P,Q). Circulating Kupffer cells and macrophages expressed MCP-1 and VEGF/R2 in the sinusoidal capillaries (Figure 3R,S). The control liver tissue showed low density of positive cells (Figure 3N).
In the lung, we observed an increase of mononuclear infiltrate around the bronchus, hyalinosis, and mononuclear infiltrate in the muscular tunic, in the pulmonary artery layers, and focal area of alveolar thickening (Ht) (Figure 4B,D). DENV NS3 protein was detected in the endothelial cells, monocytes, and macrophages in the alveolar septum (Figure 4F,G). Cells expressing CD68+ and CD8+ in the alveolar septum were observed (Figure 4I,K). TNF-α, IFN-γ, RANTES, MCP-1, VEGF/R2, and MCP-1 were detected in macrophages and endothelial cells in the pulmonary vein (Figure 4M,R). The control lung tissue showed a low density of positive cells (Figure 4L).
In the spleen, vascular congestion and follicle disorganization in the white pulp were observed (Figure 5B). DENV NS3 was detected in splenic macrophage in the follicle in germinative center of the white pulp (Figure 5D,E). CD68+ expression was observed in activated macrophage cells that presented degenerated cytoplasm (Figure 5F) and CD8+ T cells in the red pulp area (Figure 5H). TNF-α and IFN-γ were expressed in macrophages in germinal center areas in the white pulp, but around the central arteriole and splenic macrophage in the red pulp (Figure 5J,L). RANTES was also expressed in endothelial cells and macrophages with expansive cytoplasm (Figure 5M,N) and vascular mediators MCP-1 and VEGF/R2 were present in the white pulp (Figure 5O,Q). The control spleen tissue showed low density of positive cells (Figure 5I).

4. Discussion

The risk of dengue infection in pregnant women is still inconclusive and controversial [43]. However, some authors consider pregnant women more likely to progress to more severe forms of the disease [23,27,29,30,36,41]. A recent study reported that DENV vertical transmission rates might vary between 18.5% and 22.7%. Moreover, mother-to-child DENV transmission occurs both at the beginning and at the end of the pregnancy, being more frequent when maternal dengue occurs late during gestation, near delivery [24]. Evidences suggest that symptomatic dengue fever during pregnancy may be associated with adverse fetal outcomes, such as miscarriage, stillbirth, prematurity, and low birth weight [23,40,44,45,46]. Here, alterations such as inflammation, hemorrhage, edema, and necrosis were found in the placenta, brain, spleen, liver, and fetal lung. In addition, the presence of DENV-specific NS3 protein indicates viral replication in these tissues. Similar changes caused by DENV were reported in adult fatal cases [15,18,47].
Nunes et al. [48] analyzed the placenta from a DENV-2 case and reported areas of chorioangiosis and placental villous, as well as hypotrophy and infiltration of macrophages in the adventitia tunica of the artery in the umbilical cord. Similarly, Ribeiro et al. [49] analyzed placentas during dengue epidemics in Rio de Janeiro and identified signs of hypoxia, choriodeciduitis, deciduitis, and intervilositis, corroborating the observations here. However, Rabelo et al. [50] also reported the presence of large diffuse areas of fibrinoid necrosis in the maternal decidua from a zika vertical transmission, with evidenced diffuse edema, fibrosis, vascular endothelial thickening, degeneration, vascular congestion, and focal areas of mononuclear cells or perivascular inflammatory infiltrates.
The viral transmission to the fetal-placental tissues can occur through the maternal vascular endothelium to the endovascular extra viral trophoblasts; by infected maternal blood macrophages, which transmit the infection to placental trophoblasts, and by paracellular routes from maternal blood to the fetal capillaries [51,52]. Moreover, it has been reported previously that the potential mechanisms by which a maternal infection may result in fetal death outcome includes direct fetal infection and organ damage, placental infection resulting in decreased transmission of nutrients, and oxygen and maternal illness with increased production of cytokines and chemokines [53].
The role of cytokines in the pathogenesis of dengue severity has been demonstrated as a consensus that inflammatory response associated with deregulated cytokine production is critical for development of severe cases, besides the virus-mediated pathogenesis. The significant increase in several soluble inflammatory mediators, “cytokine storm”, is a well-known event and is present in the most severe forms of the disease [54]. Furthermore, activated CD4+ and CD8+ T cells generated in response to DENV infection, may produce cytokines and inflammatory mediators, lyse infected target cells for viral control, and tissue injury [55,56,57].
TNF-α is a pleiotropic cytokine that regulates many physiological and pathological functions such as cell survival, apoptosis, migration, and inflammation [58]. In fact, TNFα is associated with dengue severity in patients [59,60] inducing vascular permeability, as well as metalloproteinases [61] that would act on endothelial cells. Importantly, pregnancy is associated with a Th2 response with a decrease of Th1 induction and, the balance of pro and anti-inflammatory cytokines is critical for implantation, placental development, and pregnancy outcome [62]. However, a cytokine imbalance could be responsible for alterations in the placental environment and be involved in unexplained recurrent miscarriages. Therefore, TNF-α plays an essential role during pregnancy, especially in the trophoblast turnover and renewal. At the same time, TNF might be detrimental to pregnancy, causing complications such as miscarriage and preeclampsia [63]. RANTES is important in the recruitment of leukocytes to inflamed sites [64] and previous studies found low circulating levels of RANTES in the blood of dengue patients, while high expression was found in the hepatic tissue of fatal cases [65,66]. In severe dengue, the increased expression of RANTES, MCP-1, and VEGF/R2, associated with increased permeability of endothelial cells may be indicative of a dysfunction of the blood-brain and placental barriers, increasing viral dissemination and inflammation [67,68,69,70,71].

5. Conclusions

The production of vascular mediators during the maternal dengue infection may alter the vascular permeability, facilitating virus entry, and barrier dysfunction, mainly inflaming the placenta and fetal brain. The infection exacerbation occurs, concomitantly, with the viral spread to the peripheral regions, causing infection in DENV target organs such as the liver, lung, and spleen, which play a role on the uptake circulation of infected cells, leading to a widespread infection in the fetus. Despite the reports suggesting that stillbirth might result from direct viral transmission to the fetus, the role of the maternal infection in this outcome remains to be fully elucidated [45]. This study has some limitations and those include the quality of the record resulting in the lack of some clinical information and the fact that, after the mother’s death, no autopsy was performed, therefore, no additional tissues were available, besides the placenta.

Author Contributions

P.N., M.P., and F.d.S. conceptualized the work, P.N., F.R., N.S., C.J., K.R., and E.d.A. performed the experiments and formal analysis; P.N., J.C., R.N., and F.d.S participated directly in the investigation; R.N., J.C., F.d.S., M.P., and C.B.d.O. provided resources; P.N. and M.P. wrote the original draft of the paper; F.d.S., E.d.A., M.P., J.d.C., and C.B.d.O. reviewed and edited the paper.

Funding

To Conselho Nacional de Desenvolvimento Científico e Tecnológico/CNPq [grant number 303822/2015-5 and 155798/2014-6] and Programa Estratégico de Pesquisa em Saúde/PAPES VI-FIOCRUZ [grant number 407690/2012–3], to Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), to Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro /FAPERJ to FBS grant number E-26/202.003/2016, to FIOCRUZ, and Brazilian Ministry of Health.

Acknowledgments

We thank Ronaldo Mohana-Borges (Universidade Federal do Rio de Janeiro, Brazil) for antibodies.

Conflicts of Interest

The authors declare no conflict in interest.

References

  1. Gubler, D.J. The economic burden of dengue. Am. J. Trop. Med. Hyg. 2012, 86, 743–744. [Google Scholar] [CrossRef] [PubMed]
  2. WHO Dengue and severe dengue. Available online: http://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (accessed on 15 July 2018).
  3. Schatzmayr, H.G.; Nogueira, R.M.; Travassos da Rosa, A.P. An outbreak of dengue virus at Rio de Janeiro--1986. Mem. Inst. Oswaldo Cruz 1986, 81, 245–246. [Google Scholar] [CrossRef] [PubMed]
  4. PAHO PAHO/WHO Data—Dengue cases. Available online: http://www.paho.org/data/index.php/en/mnu-topics/indicadores-dengue-en/dengue-nacional-en/252-dengue-pais-ano-en.html (accessed on 15 July 2018).
  5. Osanai, C.H.; Travassos da Rosa, A.P.; Tang, A.T.; do Amaral, R.S.; Passos, A.D.; Tauil, P.L. [Dengue outbreak in Boa Vista, Roraima. Preliminary report]. Rev. Inst. Med. Trop. Sao Paulo 1983, 25, 53–54. [Google Scholar] [PubMed]
  6. Temporao, J.G.; Penna, G.O.; Carmo, E.H.; Coelho, G.E.; Azevedo, R.D.S.S.; Nunes, M.R.T.; da Costa Vasconcelos, P.F. Dengue Virus Serotype 4, Roraima State, Brazil. Emerg. Infect. Dis. 2011, 17, 938–940. [Google Scholar] [CrossRef] [Green Version]
  7. Nogueira, R.M.R.; Eppinghaus, A.L.F. Dengue virus type 4 arrives in the state of Rio de Janeiro: A challenge for epidemiological surveillance and control. Mem. Inst. Oswaldo Cruz 2011, 106, 255–256. [Google Scholar] [CrossRef]
  8. Heringer, M.; Souza, T.M.A.; Monique da Rocha, Q.L.; Nunes, P.C.G.; da C Faria, N.R.; de Bruycker-Nogueira, F.; Chouin-Carneiro, T.; Nogueira, R.M.R.; Dos Santos, F.B. Dengue type 4 in Rio de Janeiro, Brazil: Case characterization following its introduction in an endemic region. BMC Infect. Dis. 2017, 17, 410. [Google Scholar] [CrossRef] [PubMed]
  9. SES/SINAN Boletim Epidemiológico. Dengue: Monitoramento até a Semana Epidemiológica (SE) 52 de 2013. Available online: http://portalarquivos2.saude.gov.br/images/pdf/2013/dezembro/52/Dengue-monitoramento-2013.pdf (accessed on 17 December 2018).
  10. MS. Dengue: Diagnóstico e manejo clínico: Adulto e criança, 5th ed.; Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis: Brasília, Brazil, 2016; ISBN 978-85-334-2344-2. Available online: http://portalarquivos2.saude.gov.br/images/pdf/2016/janeiro/14/dengue-manejo-adulto-crianca-5d.pdf (accessed on 23 January 2019).
  11. World Health Organization (WHO). Dengue Guidelines for Diagnosis, Treatment, Prevention and Control; WHO: Geneva, Switzerland, 2009. [Google Scholar]
  12. Moraes, G.H.; de Fátima Duarte, E.; Duarte, E.C. Determinants of mortality from severe dengue in Brazil: A population-based case-control study. Am. J. Trop. Med. Hyg. 2013, 88, 670–676. [Google Scholar] [CrossRef]
  13. Bhamarapravati, N.; Tuchinda, P.; Boonyapaknavik, V. Pathology of Thailand haemorrhagic fever: A study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 1967, 61, 500–510. [Google Scholar] [CrossRef] [PubMed]
  14. Huerre, M.R.; Lan, N.T.; Marianneau, P.; Hue, N.B.; Khun, H.; Hung, N.T.; Khen, N.T.; Drouet, M.T.; Huong, V.T.; Ha, D.Q.; et al. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch. 2001, 438, 107–115. [Google Scholar] [PubMed]
  15. Basílio-de-Oliveira, C.A.; Aguiar, G.R.; Baldanza, M.S.; Barth, O.M.; Eyer-Silva, W.A.; Paes, M.V. Pathologic study of a fatal case of dengue-3 virus infection in Rio de Janeiro, Brazil. Braz. J. Infect. Dis. 2005, 9, 341–347. [Google Scholar] [CrossRef] [Green Version]
  16. Salgado, D.M.; Eltit, J.M.; Mansfield, K.; Panqueba, C.; Castro, D.; Vega, M.R.; Xhaja, K.; Schmidt, D.; Martin, K.J.; Allen, P.D.; et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr. Infect. Dis. J. 2010, 29, 238–242. [Google Scholar] [CrossRef] [PubMed]
  17. Bhaskar, E.; Moorthy, S. Spontaneous splenic rupture in dengue fever with non-fatal outcome in an adult. J. Infect. Dev. Ctries 2012, 6, 369–372. [Google Scholar] [CrossRef] [PubMed]
  18. Póvoa, T.F.; Alves, A.M.B.; Oliveira, C.A.B.; Nuovo, G.J.; Chagas, V.L.A.; Paes, M.V. The pathology of severe dengue in multiple organs of human fatal cases: Histopathology, ultrastructure and virus replication. PLoS ONE 2014, 9, e83386. [Google Scholar] [CrossRef] [PubMed]
  19. Burke, T. Dengue haemorrhagic fever: A pathological study. Trans. R. Soc. Trop. Med. Hyg. 1968, 62, 682–692. [Google Scholar] [CrossRef]
  20. Setlik, R.F.; Ouellette, D.; Morgan, J.; McAllister, C.K.; Dorsey, D.; Agan, B.K.; Horvath, L.; Zimmerman, M.K.; Purcell, B. Pulmonary hemorrhage syndrome associated with an autochthonous case of dengue hemorrhagic fever. South. Med. J. 2004, 97, 688–691. [Google Scholar] [CrossRef]
  21. Rao, S.; Kumar, M.; Ghosh, S.; Gadpayle, A.K. A rare case of dengue encephalitis. BMJ Case Rep. 2013, 2013, bcr2012008229. [Google Scholar] [CrossRef] [PubMed]
  22. Wakimoto, M.D.; Camacho, L.A.B.; Guaraldo, L.; Damasceno, L.S.; Brasil, P. Dengue in children: A systematic review of clinical and laboratory factors associated with severity. Expert Rev. Anti-Infect. Ther. 2015, 13, 1441–1456. [Google Scholar] [CrossRef] [PubMed]
  23. Paixao, E.S.; Harron, K.; Campbell, O.; Teixeira, M.G.; Maria da Conceição, N.C.; Barreto, M.L.; Rodrigues, L.C. Dengue in pregnancy and maternal mortality: A cohort analysis using routine data. Sci. Rep. 2018, 8, 9938. [Google Scholar] [CrossRef] [PubMed]
  24. Basurko, C.; Carles, G.; Youssef, M.; Guindi, W.E.L. Maternal and fetal consequences of dengue fever during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 147, 29–32. [Google Scholar] [CrossRef]
  25. Chansamouth, V.; Thammasack, S.; Phetsouvanh, R.; Keoluangkot, V.; Moore, C.E.; Blacksell, S.D.; Castonguay-Vanier, J.; Dubot-Pérès, A.; Tangkhabuanbutra, J.; Tongyoo, N.; et al. The Aetiologies and Impact of Fever in Pregnant Inpatients in Vientiane, Laos. PLoS. Negl. Trop. Dis. 2016, 10, e0004577. [Google Scholar] [CrossRef]
  26. Sharma, S.; Jain, S.; Rajaram, S. Spectrum of Maternofetal Outcomes during Dengue Infection in Pregnancy: An Insight. Infect. Dis. Obstet. Gynecol. 2016, 2016, 5046091. [Google Scholar] [CrossRef]
  27. Brasil, P.; Lupi, O. Dengue infection during pregnancy and risk of preterm birth. Lancet Infect. Dis. 2017, 17, 885–886. [Google Scholar] [CrossRef]
  28. Tien Dat, T.; Kotani, T.; Yamamoto, E.; Shibata, K.; Moriyama, Y.; Tsuda, H.; Yamashita, M.; Kajiyama, H.; Duc Thien Minh, D.; Quang Thanh, L.; et al. Dengue fever during pregnancy. Nagoya J. Med. Sci. 2018, 80, 241–247. [Google Scholar]
  29. Machado, C.R.; Machado, E.S.; Rohloff, R.D.; Azevedo, M.; Campos, D.P.; de Oliveira, R.B.; Brasil, P. Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system. PLoS Negl. Trop. Dis. 2013, 7, e2217. [Google Scholar] [CrossRef] [PubMed]
  30. Feitoza, H.A.C.; Koifman, S.; Koifman, R.J.; Saraceni, V. Dengue infection during pregnancy and adverse maternal, fetal, and infant health outcomes in Rio Branco, Acre State, Brazil, 2007-2012. Cad Saude Publica 2017, 33, e00178915. [Google Scholar] [PubMed]
  31. León-Juárez, M.; Martínez-Castillo, M.; González-García, L.D.; Helguera-Repetto, A.C.; Zaga-Clavellina, V.; García-Cordero, J.; Flores-Pliego, A.; Herrera-Salazar, A.; Vázquez-Martínez, E.R.; Reyes-Muñoz, E. Cellular and molecular mechanisms of viral infection in the human placenta. Pathog. Dis. 2017, 75. [Google Scholar] [CrossRef] [Green Version]
  32. Argolo, A.F.L.T.; Féres, V.C.R.; Silveira, L.A.; Oliveira, A.C.M.; Pereira, L.A.; Júnior, J.B.S.; Braga, C.; Martelli, C.M.T. Prevalence and incidence of dengue virus and antibody placental transfer during late pregnancy in central Brazil. BMC Infect. Dis. 2013, 13, 254. [Google Scholar] [CrossRef] [PubMed]
  33. Leite, R.C.; Souza, A.I.; Castanha, P.M.S.; Cordeiro, M.T.; Martelli, C.T.; Ferreira, A.L.G.; Katz, L.; Braga, C. Dengue infection in pregnancy and transplacental transfer of anti-dengue antibodies in Northeast, Brazil. J. Clin. Virol. 2014, 60, 16–21. [Google Scholar] [CrossRef] [PubMed]
  34. Castanha, P.M.S.; Braga, C.; Cordeiro, M.T.; Souza, A.I.; Silva, C.D.; Martelli, C.M.T.; van Panhuis, W.G.; Nascimento, E.J.M.; Marques, E.T.A. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants. J. Infect. Dis. 2016, 214, 265–272. [Google Scholar] [CrossRef]
  35. Ribeiro, C.F.; Lopes, V.G.S.; Brasil, P.; Silva, L.E.D.; Ribeiro, P.H.F.J.; Ugenti, L.C.; Nogueira, R.M.R. Dengue During Pregnancy: Association with Low Birth Weight and Prematurity. Rev. Inst. Med. Trop. Sao Paulo 2016, 58, 8. [Google Scholar] [CrossRef]
  36. Nascimento, L.B.D.; Siqueira, C.M.; Coelho, G.E.; Siqueira, J.B. Dengue in pregnant women: Characterization of cases in Brazil, 2007–2015. Epidemiol. Serv. Saude 2017, 26, 433–442. [Google Scholar] [CrossRef]
  37. Pengsaa, K.; Luxemburger, C.; Sabchareon, A.; Limkittikul, K.; Yoksan, S.; Chambonneau, L.; Chaovarind, U.; Sirivichayakul, C.; Lapphra, K.; Chanthavanich, P.; et al. Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children. J. Infect. Dis. 2006, 194, 1570–1576. [Google Scholar] [CrossRef] [PubMed]
  38. Chau, T.N.B.; Hieu, N.T.; Anders, K.L.; Wolbers, M.; Lien, L.B.; Hieu, L.T.M.; Hien, T.T.; Hung, N.T.; Farrar, J.; Whitehead, S.; et al. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. J. Infect. Dis. 2009, 200, 1893–1900. [Google Scholar] [CrossRef] [PubMed]
  39. Libraty, D.H.; Acosta, L.P.; Tallo, V.; Segubre-Mercado, E.; Bautista, A.; Potts, J.A.; Jarman, R.G.; Yoon, I.-K.; Gibbons, R.V.; Brion, J.D.; et al. A prospective nested case-control study of Dengue in infants: Rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med. 2009, 6, e1000171. [Google Scholar] [CrossRef] [PubMed]
  40. Kariyawasam, S.; Senanayake, H. Dengue infections during pregnancy: Case series from a tertiary care hospital in Sri Lanka. J. Infect. Dev. Ctries 2010, 4, 767–775. [Google Scholar] [CrossRef]
  41. Adam, I.; Jumaa, A.M.; Elbashir, H.M.; Karsany, M.S. Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan. Virol. J. 2010, 7, 153. [Google Scholar] [CrossRef] [PubMed]
  42. Lanciotti, R.S.; Calisher, C.H.; Gubler, D.J.; Chang, G.J.; Vorndam, A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 1992, 30, 545–551. [Google Scholar] [PubMed]
  43. Pouliot, S.H.; Xiong, X.; Harville, E.; Paz-Soldan, V.; Tomashek, K.M.; Breart, G.; Buekens, P. Maternal dengue and pregnancy outcomes: A systematic review. Obstet. Gynecol. Surv. 2010, 65, 107–118. [Google Scholar]
  44. Paixão, E.S.; Teixeira, M.G.; Maria da Conceição, N.C.; Rodrigues, L.C. Dengue during pregnancy and adverse fetal outcomes: A systematic review and meta-analysis. Lancet Infect. Dis. 2016, 16, 857–865. [Google Scholar] [CrossRef]
  45. Goldenberg, R.L.; McClure, E.M. Dengue and stillbirth. Lancet Infect. Dis. 2017, 17, 886–888. [Google Scholar] [CrossRef]
  46. Agarwal, K.; Malik, S.; Mittal, P. A retrospective analysis of the symptoms and course of dengue infection during pregnancy. Int. J. Gynaecol. Obstet. 2017, 139, 4–8. [Google Scholar] [CrossRef] [PubMed]
  47. Ahsan, J.; Ahmad, S.Q.; Rafi, T. Postmortem Findings in Fatal Dengue Haemorrhagic Fever. J. Coll. Phys. Surg. Pak. 2018, 28, S137–S139. [Google Scholar] [CrossRef] [PubMed]
  48. Nunes, P.C.G.; Paes, M.V.; de Oliveira, C.A.B.; Soares, A.C.G.; de Filippis, A.M.B.; Lima, M.R.; de Barcelos Alves, A.M.; da Silva, J.F.A.; de Oliveira Coelho, J.M.C.; de Carvalho Rodrigues, F.D.; et al. Detection of dengue NS1 and NS3 proteins in placenta and umbilical cord in fetal and maternal death. J. Med. Virol. 2016, 88, 1448–1452. [Google Scholar] [CrossRef] [PubMed]
  49. Ribeiro, C.F.; Lopes, V.G.S.; Brasil, P.; Pires, A.R.C.; Rohloff, R.; Nogueira, R.M.R. Dengue infection in pregnancy and its impact on the placenta. Int. J. Infect. Dis. 2017, 55, 109–112. [Google Scholar] [CrossRef] [PubMed]
  50. Rabelo, K.; de Souza Campos Fernandes, R.C.; de Souza, L.J.; Louvain de Souza, T.; Dos Santos, F.B.; Guerra Nunes, P.C.; de Azeredo, E.L.; Salomão, N.G.; Trindade, G.F.; Basílio-de-Oliveira, C.A.; et al. Placental Histopathology and Clinical Presentation of Severe Congenital Zika Syndrome in a Human Immunodeficiency Virus-Exposed Uninfected Infant. Front. Immunol. 2017, 8, 1704. [Google Scholar] [CrossRef] [Green Version]
  51. Delorme-Axford, E.; Sadovsky, Y.; Coyne, C.B. The Placenta as a Barrier to Viral Infections. Annu. Rev. Virol. 2014, 1, 133–146. [Google Scholar] [CrossRef]
  52. Coyne, C.B. The Tree(s) of Life: The Human Placenta and My Journey to Learn More about It. PLoS Pathog. 2016, 12, e1005515. [Google Scholar] [CrossRef]
  53. McClure, E.M.; Goldenberg, R.L. Infection and stillbirth. Semin. Fetal Neonatal Med. 2009, 14, 182–189. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Lee, Y.H.; Leong, W.-Y.; Wilder-Smith, A. Markers of dengue severity: A systematic review of cytokines and chemokines. J. Gen. Virol. 2016, 97, 3103–3119. [Google Scholar] [CrossRef]
  55. Kurane, I.; Innis, B.L.; Nisalak, A.; Hoke, C.; Nimmannitya, S.; Meager, A.; Ennis, F.A. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J. Clin. Investig. 1989, 83, 506–513. [Google Scholar] [CrossRef]
  56. Kurane, I.; Matsutani, T.; Suzuki, R.; Takasaki, T.; Kalayanarooj, S.; Green, S.; Rothman, A.L.; Ennis, F.A. T-cell responses to dengue virus in humans. Trop. Med. Health 2011, 39, 45–51. [Google Scholar] [CrossRef] [PubMed]
  57. Gagnon, S.J.; Ennis, F.A.; Rothman, A.L. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J. Virol. 1999, 73, 3623–3629. [Google Scholar] [PubMed]
  58. Locksley, R.M.; Killeen, N.; Lenardo, M.J. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001, 104, 487–501. [Google Scholar] [CrossRef]
  59. Braga, E.L.; Moura, P.; Pinto, L.M.; Ignácio, S.R.; Oliveira, M.J.; Cordeiro, M.T.; Kubelka, C.F. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem. Inst. Oswaldo Cruz 2001, 96, 229–232. [Google Scholar] [CrossRef] [PubMed]
  60. Bozza, F.A.; Cruz, O.G.; Zagne, S.M.O.; Azeredo, E.L.; Nogueira, R.M.R.; Assis, E.F.; Bozza, P.T.; Kubelka, C.F. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 2008, 8, 86. [Google Scholar] [CrossRef] [PubMed]
  61. Kubelka, C.F.; Azeredo, E.L.; Gandini, M.; Oliveira-Pinto, L.M.; Barbosa, L.S.; Damasco, P.V.; Avila, C.A.L.; Motta-Castro, A.R.C.; Cunha, R.V.; Cruz, O.G. Metalloproteinases are produced during dengue fever and MMP9 is associated with severity. J. Infect. 2010, 61, 501–505. [Google Scholar] [CrossRef]
  62. Wegmann, T.G.; Lin, H.; Guilbert, L.; Mosmann, T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol. Today 1993, 14, 353–356. [Google Scholar] [CrossRef]
  63. Haider, S.; Knöfler, M. Human tumour necrosis factor: Physiological and pathological roles in placenta and endometrium. Placenta 2009, 30, 111–123. [Google Scholar] [CrossRef]
  64. Aldinucci, D.; Colombatti, A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014, 2014, 292376. [Google Scholar] [CrossRef]
  65. De-Oliveira-Pinto, L.M.; Marinho, C.F.; Povoa, T.F.; de Azeredo, E.L.; de Souza, L.A.; Barbosa, L.D.R.; Motta-Castro, A.R.C.; Alves, A.M.B.; Ávila, C.A.L.; de Souza, L.J.; et al. Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PLoS ONE 2012, 7, e38527. [Google Scholar] [CrossRef]
  66. Póvoa, T.F.; Oliveira, E.R.A.; Basílio-de-Oliveira, C.A.; Nuovo, G.J.; Chagas, V.L.A.; Salomão, N.G.; Mota, E.M.; Paes, M.V. Peripheral Organs of Dengue Fatal Cases Present Strong Pro-Inflammatory Response with Participation of IFN-Gamma-, TNF-Alpha- and RANTES-Producing Cells. PLoS ONE 2016, 11, e0168973. [Google Scholar] [CrossRef] [PubMed]
  67. Stamatovic, S.M.; Keep, R.F.; Kunkel, S.L.; Andjelkovic, A.V. Potential role of MCP-1 in endothelial cell tight junction “opening”: Signaling via Rho and Rho kinase. J. Cell. Sci. 2003, 116, 4615–4628. [Google Scholar] [CrossRef] [PubMed]
  68. Yamada, M.; Kim, S.; Egashira, K.; Takeya, M.; Ikeda, T.; Mimura, O.; Iwao, H. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1996–2001. [Google Scholar] [CrossRef] [PubMed]
  69. Gille, H.; Kowalski, J.; Li, B.; LeCouter, J.; Moffat, B.; Zioncheck, T.F.; Pelletier, N.; Ferrara, N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 2001, 276, 3222–3230. [Google Scholar] [CrossRef] [PubMed]
  70. Tseng, C.-S.; Lo, H.-W.; Teng, H.-C.; Lo, W.-C.; Ker, C.-G. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 2005, 43, 99–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Srikiatkhachorn, A.; Ajariyakhajorn, C.; Endy, T.P.; Kalayanarooj, S.; Libraty, D.H.; Green, S.; Ennis, F.A.; Rothman, A.L. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J. Virol. 2007, 81, 1592–1600. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Histopathological and immunohistochemistry analysis of the fetal brain. (A) Brain of a non-DENV case presenting normal aspect: cerebral cortex (CC) and neurons (Ne). (B) White matter (WM) region of the stillborn brain presenting neuropile (Np) and microglial cells (MC). (C) DENV NS3 staining by immunohistochemistry in negative control. (D) DENV NS3 protein present in circulating macrophages (Mø) and endothelial cells (En) in blood vessels in the meningeal region and (E) microglial cells (MC) in WM. CD68 detection in negative control (F) and DENV case (G). CD8+ T cell detection in vessels in negative control (H), meningel region (I) and parenchyma (J) both in DENV cases. (K) Representative negative control non-DENV of cytokine and inflammatory mediators. (L) Endothelial cells (En) TNF-α expressing in DENV-case. IFN-γ (M), RANTES (N), MCP-1 (O), and VEGF/R2 (P) expressing in microglial cells (MC) from DENV-case parenchyma.
Figure 1. Histopathological and immunohistochemistry analysis of the fetal brain. (A) Brain of a non-DENV case presenting normal aspect: cerebral cortex (CC) and neurons (Ne). (B) White matter (WM) region of the stillborn brain presenting neuropile (Np) and microglial cells (MC). (C) DENV NS3 staining by immunohistochemistry in negative control. (D) DENV NS3 protein present in circulating macrophages (Mø) and endothelial cells (En) in blood vessels in the meningeal region and (E) microglial cells (MC) in WM. CD68 detection in negative control (F) and DENV case (G). CD8+ T cell detection in vessels in negative control (H), meningel region (I) and parenchyma (J) both in DENV cases. (K) Representative negative control non-DENV of cytokine and inflammatory mediators. (L) Endothelial cells (En) TNF-α expressing in DENV-case. IFN-γ (M), RANTES (N), MCP-1 (O), and VEGF/R2 (P) expressing in microglial cells (MC) from DENV-case parenchyma.
Viruses 11 00319 g001
Figure 2. Histopathological and immunohistochemistry analysis of the placenta. (A) Non-DENV patient stained with HE and presenting normal maternal decidua (D) and blood vessels (V). (B) Maternal decidua (D) from the DENV case presenting focal hemorrhage and lymphocytic infiltrates. (C) Chorionic villus with mononuclear infiltrate (Mo) and haemorrhage (He) and also intervillus space in the DENV case. (D) Placenta control with no DENV NS3 protein detection. (E) DENV NS3 protein detection in endothelial cells (En) from the maternal vessel, (F) in the cytotrophoblasts (CTB) and Hofbauer cells (Hf), (G) in decidual cells (DC), and macrophages (Mø) in the infected placenta. (H) CD68 detection in negative control and in the DENV case (I,J). (K) CD8+ T cells detection in negative control and in the DENV case (LN). (O,P) Representative negative control of cytokine and inflammatory mediators from a non-DENV case (Q,R) Expressing TNF-α in macrophages (Mø) and Hofbauer cells (Hf) in the DENV-case. (S) Expressing IFN-y in macrophages (Mø) in maternal region, (T) in Macrophages (Mø) and cytotrophoblasts (CTB) in chorionic villi. (U) Expressing RANTES in Macrophages (Mø), endothelial cells (En), and lymphocytes (Ly) in the maternal region. (V) Endothelial cells (En) expressing MCP-1 in the maternal region and, (W) endothelial cells (En), and Hofbauer cells (Hf), both in chorionic villi. (XZ) Macrophages (Mø), endothelial cells (En) and lymphocytes (Ly) expressing VEGF/R2.
Figure 2. Histopathological and immunohistochemistry analysis of the placenta. (A) Non-DENV patient stained with HE and presenting normal maternal decidua (D) and blood vessels (V). (B) Maternal decidua (D) from the DENV case presenting focal hemorrhage and lymphocytic infiltrates. (C) Chorionic villus with mononuclear infiltrate (Mo) and haemorrhage (He) and also intervillus space in the DENV case. (D) Placenta control with no DENV NS3 protein detection. (E) DENV NS3 protein detection in endothelial cells (En) from the maternal vessel, (F) in the cytotrophoblasts (CTB) and Hofbauer cells (Hf), (G) in decidual cells (DC), and macrophages (Mø) in the infected placenta. (H) CD68 detection in negative control and in the DENV case (I,J). (K) CD8+ T cells detection in negative control and in the DENV case (LN). (O,P) Representative negative control of cytokine and inflammatory mediators from a non-DENV case (Q,R) Expressing TNF-α in macrophages (Mø) and Hofbauer cells (Hf) in the DENV-case. (S) Expressing IFN-y in macrophages (Mø) in maternal region, (T) in Macrophages (Mø) and cytotrophoblasts (CTB) in chorionic villi. (U) Expressing RANTES in Macrophages (Mø), endothelial cells (En), and lymphocytes (Ly) in the maternal region. (V) Endothelial cells (En) expressing MCP-1 in the maternal region and, (W) endothelial cells (En), and Hofbauer cells (Hf), both in chorionic villi. (XZ) Macrophages (Mø), endothelial cells (En) and lymphocytes (Ly) expressing VEGF/R2.
Viruses 11 00319 g002
Figure 3. Histopathological and immunohistochemistry analysis of the liver. (A) Liver of a non-dengue case stained with HE, presenting a normal central vein (CV) aspect. Stillborn liver with lymphocytes infiltrate (Ly) in the lobular center (B), (C) area of necrotic hepatocytes (Ne), with normal bile duct (BD) and lymphocytes infiltrate (Ly) in the peri-portal vein (PV), (D) thickening of the endothelium (En) in the lobular center and presence of hemorrhage (He). (E) Sinusoids capillaries of the negative control without DENV NS3 staining. (F) DENV NS3 protein in Kupffer cells (HPC) and hepatocytes (Hp) near the sinusoids capillaries. CD68 cells staining in the control (G) and in the dengue case (H). No evidence of CD4+ (I) and CD8+ T cells (L) in the negative control. CD4+ (J,K) and CD8+ (M) T cells detection in the dengue case. (N) Representative negative control of cytokine and inflammatory mediators from a non-DENV case. (O) TNF-α expression in macrophages (Mø) and lymphocytes (Ly). (P,R,S) IFN-γ, MCP-1, and VEGF/R2 in macrophages (Mø) and Kupffer cells (HPC). (Q) RANTES expression in Kupffer cells (HPC).
Figure 3. Histopathological and immunohistochemistry analysis of the liver. (A) Liver of a non-dengue case stained with HE, presenting a normal central vein (CV) aspect. Stillborn liver with lymphocytes infiltrate (Ly) in the lobular center (B), (C) area of necrotic hepatocytes (Ne), with normal bile duct (BD) and lymphocytes infiltrate (Ly) in the peri-portal vein (PV), (D) thickening of the endothelium (En) in the lobular center and presence of hemorrhage (He). (E) Sinusoids capillaries of the negative control without DENV NS3 staining. (F) DENV NS3 protein in Kupffer cells (HPC) and hepatocytes (Hp) near the sinusoids capillaries. CD68 cells staining in the control (G) and in the dengue case (H). No evidence of CD4+ (I) and CD8+ T cells (L) in the negative control. CD4+ (J,K) and CD8+ (M) T cells detection in the dengue case. (N) Representative negative control of cytokine and inflammatory mediators from a non-DENV case. (O) TNF-α expression in macrophages (Mø) and lymphocytes (Ly). (P,R,S) IFN-γ, MCP-1, and VEGF/R2 in macrophages (Mø) and Kupffer cells (HPC). (Q) RANTES expression in Kupffer cells (HPC).
Viruses 11 00319 g003
Figure 4. Histopathological and immunohistochemistry analysis of the lung. (A) Lung of a non-dengue case. In the stillborn lung, we observed the (B) presence of mononuclear infiltrates (IM) around the bronchus and hyalinosis (Hy). (C) Mononuclear infiltrates (IM) in the muscular tunica and (D) focal area of alveolar hyalinosis (Hy) with mononuclear infiltrate (IM). (E) Negative control without DENV NS3 staining. (F) Detection of DENV NS3 in monocytes (Mo) and endothelial cells (En) in vessels and (G) macrophage (Mø), in the alveolar space. (H,I) Presence of CD68 and (J,K) CD8+ T cells in the alveolar space. (L) Representative negative control of cytokine and inflammatory mediators from a non-DENV case. (M) TNF-α in mononuclear infiltrate (IM) (N) IFN-γ in macrophages and endothelial cells (En), (O) RANTES in macrophages (Mø), (P,Q) MCP-1 in endothelial cells (En), alveolar macrophages (AM), and (R) VEGF/R2 in macrophages (Mø).
Figure 4. Histopathological and immunohistochemistry analysis of the lung. (A) Lung of a non-dengue case. In the stillborn lung, we observed the (B) presence of mononuclear infiltrates (IM) around the bronchus and hyalinosis (Hy). (C) Mononuclear infiltrates (IM) in the muscular tunica and (D) focal area of alveolar hyalinosis (Hy) with mononuclear infiltrate (IM). (E) Negative control without DENV NS3 staining. (F) Detection of DENV NS3 in monocytes (Mo) and endothelial cells (En) in vessels and (G) macrophage (Mø), in the alveolar space. (H,I) Presence of CD68 and (J,K) CD8+ T cells in the alveolar space. (L) Representative negative control of cytokine and inflammatory mediators from a non-DENV case. (M) TNF-α in mononuclear infiltrate (IM) (N) IFN-γ in macrophages and endothelial cells (En), (O) RANTES in macrophages (Mø), (P,Q) MCP-1 in endothelial cells (En), alveolar macrophages (AM), and (R) VEGF/R2 in macrophages (Mø).
Viruses 11 00319 g004
Figure 5. Histopathological and immunohistochemistry analysis of the spleen. (A) Spleen of a non-dengue case. (B) In the stillborn spleen, hemorrhage (He) in the red and white pulps, and follicle disorganization (FD) in the white pulp, were observed. (C) Negative control without NS3 staining. (D) Detection of DENV NS3 protein in macrophage (Mø). (E,F) Presence of CD68. Negative control without TCD8+ cells (G). (H) Presence of T CD8+ cells in red pulp. (I) Representative negative control of cytokine and inflammatory mediators from a non-DENV case. (J,K) TNF-α in macrophages (Mø), endothelial cells (En), and lymphocytes (Ly), (L) IFN-y in macrophages, (M,N) RANTES in macrophages (Mø), endothelial cells (En) and monocytes (Mo), (O,P) MCP-1 in macrophages (Mø), lymphocytes (Ly), and (Q) VEGF/R2 only in macrophages (Mø).
Figure 5. Histopathological and immunohistochemistry analysis of the spleen. (A) Spleen of a non-dengue case. (B) In the stillborn spleen, hemorrhage (He) in the red and white pulps, and follicle disorganization (FD) in the white pulp, were observed. (C) Negative control without NS3 staining. (D) Detection of DENV NS3 protein in macrophage (Mø). (E,F) Presence of CD68. Negative control without TCD8+ cells (G). (H) Presence of T CD8+ cells in red pulp. (I) Representative negative control of cytokine and inflammatory mediators from a non-DENV case. (J,K) TNF-α in macrophages (Mø), endothelial cells (En), and lymphocytes (Ly), (L) IFN-y in macrophages, (M,N) RANTES in macrophages (Mø), endothelial cells (En) and monocytes (Mo), (O,P) MCP-1 in macrophages (Mø), lymphocytes (Ly), and (Q) VEGF/R2 only in macrophages (Mø).
Viruses 11 00319 g005

Share and Cite

MDPI and ACS Style

Nunes, P.; Nogueira, R.; Coelho, J.; Rodrigues, F.; Salomão, N.; José, C.; de Carvalho, J.; Rabelo, K.; de Azeredo, E.; Basílio-de-Oliveira, R.; et al. A Stillborn Multiple Organs’ Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization. Viruses 2019, 11, 319. https://doi.org/10.3390/v11040319

AMA Style

Nunes P, Nogueira R, Coelho J, Rodrigues F, Salomão N, José C, de Carvalho J, Rabelo K, de Azeredo E, Basílio-de-Oliveira R, et al. A Stillborn Multiple Organs’ Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization. Viruses. 2019; 11(4):319. https://doi.org/10.3390/v11040319

Chicago/Turabian Style

Nunes, Priscila, Rita Nogueira, Janice Coelho, Francisco Rodrigues, Natália Salomão, Carollina José, Jorge de Carvalho, Kíssila Rabelo, Elzinandes de Azeredo, Rodrigo Basílio-de-Oliveira, and et al. 2019. "A Stillborn Multiple Organs’ Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization" Viruses 11, no. 4: 319. https://doi.org/10.3390/v11040319

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop